Money Surgery Holdings Limited

	Page
Balance Sheet	1
Notes to the Financial Statements	2—3

Registered number: 09153311

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Investments	4		950,000		950,000

			950,000		950,000
Creditors: Amounts Falling Due Within One Year	5	(1,058,948 )		(974,291 )

NET CURRENT ASSETS (LIABILITIES)			(1,058,948 )		(974,291 )

TOTAL ASSETS LESS CURRENT LIABILITIES			(108,948 )		(24,291 )

Creditors: Amounts Falling Due After More Than One Year	6		(620,533 )		(620,533 )

NET LIABILITIES			(729,481 )		(644,824 )

CAPITAL AND RESERVES
Called up share capital	7		100		100
Profit and Loss Account			(729,581 )		(644,924 )

SHAREHOLDERS' FUNDS			(729,481)		(644,824)

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr A Mellor

Director

11 December 2025

The notes on pages 2 to 3 form part of these financial statements.

1. General Information

Money Surgery Holdings Limited is a private company, limited by shares, incorporated in England & Wales, registered number 09153311 . The registered office is 2nd Floor, Pickford Steet Mill, Pickford Street, Macclesfield, SK11 6JD.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Going Concern Disclosure

The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern.

The company made a loss for the year of £84,657 (2024: £79,987) and at the balance sheet date had net current liabilities of £1,058,948 (2024: £974,290). The company is therefore reliant upon the continued support of its related party creditors. It has been indicated that this support will continue for the foreseeable future. The directors therefore consider it appropriate to prepare the financial statements on a going concern basis.

2.3. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.

2.4. Fixed Asset Investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in proft or loss.

3. Average Number of Employees

Average number of employees, including directors, during the year was: NIL (2024: NIL)

Page 2

Page 3

Money Surgery Holdings Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 March 2025

4. Investments

	Subsidiaries
	£
Cost or Valuation
As at 1 April 2024	950,000

As at 31 March 2025	950,000

Provision
As at 1 April 2024	-

As at 31 March 2025	-

Net Book Value
As at 31 March 2025	950,000

As at 1 April 2024	950,000

5. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Amounts owed to group undertakings	1,044,052	957,737
Other creditors	14,896	16,554

	1,058,948	974,291

6. Creditors: Amounts Falling Due After More Than One Year

	2025	2024
	£	£
Other creditors	620,533	620,533

The Seneca Capital No2 LP Investor loan notes totalling £620,533 (2024: £620,533) are secured against all company assets.

7. Share Capital

	2025	2024
Allotted, called up and fully paid	£	£
850 Ordinary A shares of £ 0.10 each	85	85
100 Ordinary B shares of £ 0.10 each	10	10
50 Ordinary C shares of £ 0.10 each	5	5

	100	100

8. Related Party Transactions

The company is the parent company of The Insurance Surgery Limited and therefore the aforementioned is a related party. At the year end the company owed The Insurance Surgery Limited £1,044,052 (2024:£957,737). The loan is interest free with no fixed date of repayment.

Seneca Capital No2 LP has a 85% shareholding of the alloted share capital in the company and therefore is a related party. During the year, the company has paid monitoring fees of £28,800 (2024: £28,800) to Seneca Capital No2 LP.

At the year end, the company owed Seneca Capital No2 LP Investor loan notes of £620,533 (2024: £620,533). During the year, the company paid loan note interest of £55,857 (2024: £51,187). At the year end, £14,895 (2024: £16,554) of this loan interest was accrued.

9. Ultimate Controlling Party

The company's ultimate controlling party and ultimate parent company is Seneca Capital No2 LP by virtue of his ownership of 85% of the issued share capital in the company.

Page 3